Pediatrix Medical Group (MD) Competitors

Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Is AMED or MD more profitable?

Amedisys has a net margin of 3.79% compared to Pediatrix Medical Group's net margin of -4.17%. Pediatrix Medical Group's return on equity of 17.43% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amedisys	3.79%	12.52%	7.01%
Pediatrix Medical Group	-4.17%	17.43%	6.35%

Do analysts recommend AMED or MD?

Amedisys presently has a consensus target price of $100.75, indicating a potential upside of 3.35%. Pediatrix Medical Group has a consensus target price of $16.67, indicating a potential upside of 30.09%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amedisys	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Pediatrix Medical Group	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do insiders & institutionals have more ownership in AMED or MD?

94.4% of Amedisys shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 2.1% of Amedisys shares are owned by company insiders. Comparatively, 0.9% of Pediatrix Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the media refer more to AMED or MD?

In the previous week, Amedisys had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 3 mentions for Amedisys and 1 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.68 beat Amedisys' score of 1.22 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amedisys	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pediatrix Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has higher earnings & valuation, AMED or MD?

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amedisys	$2.35B	1.36	$43.23M	$2.71	35.97
Pediatrix Medical Group	$2.01B	0.55	-$99.07M	-$1.01	-12.69

Which has more risk and volatility, AMED or MD?

Amedisys has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Summary

Amedisys beats Pediatrix Medical Group on 9 of the 16 factors compared between the two stocks.